首页> 外文期刊>Pharmaceutical development and technology >Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
【24h】

Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.

机译:Carbopol 71G-NF对氢溴酸右美沙芬从缓释基质片剂中释放的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to evaluate the potential of Carbopol(?) 71G-NF on the release of dextromethorphan hydrobromide (DM) from matrix tablets in comparison with hydroxypropyl methylcellulose (HPMC(?) K15M) and Eudragit(?) L100-55 polymers. Controlled release DM matrix tablets were prepared using Carbopol 71G-NF, HPMC K15M, and Eudragit L100-55 at different drug to polymer ratios by direct compression technique. The mechanical properties of the tablets as tested by crushing strength and friability tests were improved as the concentration of Carbopol, HPMC, and Eudragit increased. However, Carbopol-based tablets showed a significantly (P<0.05) higher crushing strength and a lower friability than HPMC and Eudragit tablets. No significant differences in weight uniformity and thickness values were observed between the different formulations. It was also found that Carbopol significantly (P<0.05) delayed the release of DM in comparison with HPMC K15M and Eudragit L100-55. A combination of HPMC K15M and Eudragit L100-55 in a 1:1 ratio at 20 and 30% significantly (P<0.05) delayed the release of DM than Eudragit L100-55 alone. Moreover, blends of Carbopol and HPMC at a 1:1 ratio at the 10, 20, and 30% total polymer concentration were investigated. The blend of Carbopol and HPMC at 10% level significantly (P<0.05) slowed the release of DM than Carbopol or HPMC alone, whereas blends at 20 and 30% level significantly (P<0.05) delayed the release of DM compared with HPMC or Carbopol alone. The results with these polymer blends showed that it was possible to reduce the total amount of polymers when used as a combination in formulation.
机译:这项研究的目的是评估与羟丙基甲基纤维素(HPMC(?)K15M)和Eudragit(?)L100-55相比,Carbopol(?)71G-NF在从基质片剂中释放氢溴酸右美沙芬(DM)的潜力。聚合物。通过直接压片技术,使用Carbopol 71G-NF,HPMC K15M和Eudragit L100-55以不同的药物/聚合物比例制备控释DM基质片剂。随着Carbopol,HPMC和Eudragit的浓度增加,通过压碎强度和脆性测试测试的片剂机械性能得到改善。但是,与HPMC和Eudragit片剂相比,基于Carbopol的片剂显示出显着(P <0.05)的抗碎强度和更低的脆碎度。在不同配方之间未观察到重量均匀度和厚度值的显着差异。还发现与HPMC K15M和Eudragit L100-55相比,Carbopol显着(P <0.05)延迟了DM的释放。 HPMC K15M和Eudragit L100-55以1:1的比例分别以20%和30%的比例结合使用(P <0.05)(P <0.05)比单独使用Eudragit L100-55延迟DM的释放。此外,研究了总聚合物浓度为10%,20%和30%时Carbopol和HPMC的比例为1:1的共混物。与单独的Carbopol或HPMC相比,Carbopol和HPMC的共混物的10%水平显着降低(P <0.05),而与HPMC或HPMC相比,在20%和30%的共混物显着(P <0.05)延迟DM的释放。单独的Carbopol。这些聚合物共混物的结果表明,当在配方中组合使用时,可以减少聚合物的总量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号